International Journal of Infection

Published by: Neoscriber Demo Publisher
Crossmark

Antibacterial Effect of Zinc Oxide Nanoparticles on Group A β-Hemolytic Streptococci with Macrolide Resistance Isolated from University Student Carriers in North of Iran

Leila Fozouni ORCID 1 , * , Sepideh Javidmehr 1 , Hadiseh Barghamadi 1 , Anahita Mazandarani 1 and Somaye Rouhafza 1
Authors Information
1 Department of Biology, Gorgan Branch, Islamic Azad University, Gorgan, Iran
Article information
  • International Journal of Infection: January 31, 2019, 6 (1); e85732
  • Published Online: January 20, 2019
  • Article Type: Research Article
  • Received: October 24, 2018
  • Revised: December 3, 2018
  • Accepted: December 6, 2018
  • DOI: 10.5812/iji.85732

To Cite: Fozouni L, Javidmehr S, Barghamadi H, Mazandarani A, Rouhafza S. Antibacterial Effect of Zinc Oxide Nanoparticles on Group A β-Hemolytic Streptococci with Macrolide Resistance Isolated from University Student Carriers in North of Iran, Int J Infect. 2019 ; 6(1):e85732. doi: 10.5812/iji.85732.

Abstract
Copyright © 2019, International Journal of Infection. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Kliegman RM, Behrman RE, Hal BJ, Stanton BF. Nelson textbook of pediatrics. 18th ed. Philadelphia: WB. Saunders; 2007. p. 1135-9.
  • 2. Brook I, Dohar JE. Management of group A beta-hemolytic streptococcal pharyngotonsillitis in children. J Fam Pract. 2006;55(12):1-11.
  • 3. Kern L, Rassbach C, Ottolini M. Streptococcal pyomyositis of the psoas: Case reports and review. Pediatr Emerg Care. 2006;22(4):250-3. doi: 10.1097/01.pec.0000210177.48386.e7. [PubMed: 16651916].
  • 4. Mandell GL, Bennett JE, Dolin R. Principles and practice of infectious disease. 6th ed. Philadelphia: Churchill Livingstone; 2005.
  • 5. Kasper DL, Braunwald E, Hauser S, Longo D, Jameson JL, Fauci AS. Harison s principles of internal medicine. 16th ed. New York: Elsevier; 2005. p. 824-5.
  • 6. Cohen R. Defining the optimum treatment regimen for azithromycin in acute tonsillopharyngitis. Pediatr Infect Dis J. 2004;23(2 Suppl):S129-34. doi: 10.1097/01.inf.0000112527.33870.0d. [PubMed: 14770076].
  • 7. Kanungo R. Macrolide resistance mechanisms in Streptococcus pneumoniae: Opening Pandora's box. Indian J Med Microbiol. 2016;34(1):5-6. doi: 10.4103/0255-0857.174123. [PubMed: 26776111].
  • 8. Rudolph K, Bulkow L, Bruce M, Zulz T, Reasonover A, Harker-Jones M, et al. Molecular resistance mechanisms of macrolide-resistant invasive Streptococcus pneumoniae isolates from Alaska, 1986 to 2010. Antimicrob Agents Chemother. 2013;57(11):5415-22. doi: 10.1128/AAC.00319-13. [PubMed: 23959308]. [PubMed Central: PMC3811267].
  • 9. Bley C, van der Linden M, Reinert RR. mef(A) is the predominant macrolide resistance determinant in Streptococcus pneumoniae and Streptococcus pyogenes in Germany. Int J Antimicrob Agents. 2011;37(5):425-31. doi: 10.1016/j.ijantimicag.2011.01.019. [PubMed: 21419605].
  • 10. Zhang L, Ding Y, Povey M, York D. ZnO nanofluids – A potential antibacterial agent. Progress in Natural Science. 2008;18(8):939-44. doi: 10.1016/j.pnsc.2008.01.026.
  • 11. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing: M100-S17. 2008. 181 p.
  • 12. Bingen E, Fitoussi F, Doit C, Cohen R, Tanna A, George R, et al. Resistance to macrolides in Streptococcus pyogenes in France in pediatric patients. Antimicrob Agents Chemother. 2000;44(6):1453-7. [PubMed: 10817692]. [PubMed Central: PMC89896].
  • 13. Goldman L, Ausiello D. Cecil textbook of medicine. 22nd ed. Philadelphia: WB; 2004. p. 1782-6.
  • 14. Mohsenimoghaddam F, Shahidizandi B, Shabani Shahrbabak Z, Rezaeian M, Jafarpour P, Hadavi M. [Antibiotic resistance pattern on beta hemolytic (A) streptococci among Rafsanjan's secondary school pupils in 2009]. J Rafsanjan Univ Med Sci. 2013;12(4):291-8. Persian.
  • 15. Nabipoor F, Tayarzadeh MA. [Beta hemolytic group a Streptococcal drug resistant to penicillinamong asymptomatic carriers]. Zahedan J Res Med Sci. 2006;7(2):131-8. Persian.
  • 16. Kocoglu E, Karabay O, Yilmaz F, Ekerbicer H. The impact of incubating the throat culture for 72 h on the diagnosis of group A beta-hemolytic streptococci. Auris Nasus Larynx. 2006;33(3):311-3. doi: 10.1016/j.anl.2005.11.011. [PubMed: 16431061].
  • 17. Tarvij Eslami S, Nasirian H. [Once-daily therapy for streptococcal pharyngitis with amoxicillin vs. Intramuscular benzathin penicillin G]. Iran J Pediatr. 2007;17(2):161-6. Persian.
  • 18. Gordon KA, Beach ML, Biedenbach DJ, Jones RN, Rhomberg PR, Mutnick AH. Antimicrobial susceptibility patterns of beta-hemolytic and viridans group streptococci: Report from the SENTRY Antimicrobial Surveillance Program (1997-2000). Diagn Microbiol Infect Dis. 2002;43(2):157-62. doi: 10.1016/S0732-8893(02)00374-7. [PubMed: 12088624].
  • 19. Ghaemi E, Tabarrayii A, Fazeli MR, Vakili MA, Bazouri M. [Prevalence of group A streptococcal carriers among school going children of Gorgan]. J Gorgan Univ Med Sci. 2000;6(2):55-61. Persian.
  • 20. Durmaz R, Durmaz B, Bayraktar M, Ozerol IH, Kalcioglu MT, Aktas E, et al. Prevalence of group A streptococcal carriers in asymptomatic children and clonal relatedness among isolates in Malatya, Turkey. J Clin Microbiol. 2003;41(11):5285-7. doi: 10.1128/JCM.41.11.5285-5287.2003. [PubMed: 14605185]. [PubMed Central: PMC262532].
  • 21. Sharefiyan MR, Rashed T, Hetror H. [Study of aerobic bacterial growth and their antibiogram among 105 pharyngeal patients in Medical Center of Imam Reza]. Iran J Otorhinolaryngol. 2005;17(40):5-10. Persian.
  • 22. Cengiz AT, Kiyan M, Ciftcioglu N. [Antibiotic susceptibility of group A beta hemolytic Streptococcus]. Mikrobiyol Bul. 1989;23(2):163-73. Turkish. [PubMed: 2696867].
  • 23. Brook I. Treatment challenges of group a beta-hemolytic streptococcal pharyngo-tonsillitis. Int Arch Otorhinolaryngol. 2017;21(3):286-96. doi: 10.1055/s-0036-1584294. [PubMed: 28680500]. [PubMed Central: PMC5495595].
  • 24. Pavlovic L, Grego E, Sipetic-Grujicic S. Prevalence of macrolide resistance in Streptococcus pyogenes collected in Serbia. Jpn J Infect Dis. 2010;63(4):275-6. [PubMed: 20657068].
  • 25. Luca-Harari B, Straut M, Cretoiu S, Surdeanu M, Ungureanu V, van der Linden M, et al. Molecular characterization of invasive and non-invasive Streptococcus pyogenes isolates from Romania. J Med Microbiol. 2008;57(Pt 11):1354-63. doi: 10.1099/jmm.0.2008/001875-0. [PubMed: 18927412].
  • 26. Koh E, Kim S. Decline in erythromycin resistance in group A Streptococci from acute pharyngitis due to changes in the emm Genotypes rather than restriction of antibiotic use. Korean J Lab Med. 2010;30(5):485-90. doi: 10.3343/kjlm.2010.30.5.485. [PubMed: 20890080].
  • 27. d'Humieres C, Cohen R, Levy C, Bidet P, Thollot F, Wollner A, et al. Decline in macrolide-resistant Streptococcus pyogenes isolates from French children. Int J Med Microbiol. 2012;302(7-8):300-3. doi: 10.1016/j.ijmm.2012.09.001. [PubMed: 23103047].
  • 28. Chang H, Shen X, Fu Z, Liu L, Shen Y, Liu X, et al. Antibiotic resistance and molecular analysis of Streptococcus pyogenes isolated from healthy schoolchildren in China. Scand J Infect Dis. 2010;42(2):84-9. doi: 10.3109/00365540903321598. [PubMed: 19883153].
  • 29. Del Grosso M, Camilli R, Barbabella G, Blackman Northwood J, Farrell DJ, Pantosti A. Genetic resistance elements carrying mef subclasses other than mef(A) in Streptococcus pyogenes. Antimicrob Agents Chemother. 2011;55(7):3226-30. doi: 10.1128/AAC.01713-10. [PubMed: 21502613]. [PubMed Central: PMC3122394].
  • 30. Ashja Ardalan A, Keshavarzi F, Fattahy Rad A, Baghbani-Arani F. [Determination of mef genotype in Beta-hemolytic streptococci group A strains isolated from patients in Sanandaj city]. Sci J Kurdistan Univ Med Sci. 2016;21:29-40. Persian.
  • 31. Kargar M, Baghernejad M, Ghorbani-Dalini S, Hashemizadeh Z. [Evaluation of molecular mechanisms resistance to macrolide by S. pneumonia strains isolated from Nemazee and Shahid Faghihi Hospitals in Shiraz]. Sci J Kurdistan Univ Med Sci. 2012;16:83-91. Persian.
  • 32. D'Ercole S, Petrelli D, Prenna M, Zampaloni C, Catania MR, Ripa S, et al. Distribution of mef(A)-containing genetic elements in erythromycin-resistant isolates of Streptococcus pyogenes from Italy. Clin Microbiol Infect. 2005;11(11):927-30. doi: 10.1111/j.1469-0691.2005.01250.x. [PubMed: 16216111].
  • 33. El Ashkar S, Osman M, Rafei R, Mallat H, Achkar M, Dabboussi F, et al. Molecular detection of genes responsible for macrolide resistance among Streptococcus pneumoniae isolated in North Lebanon. J Infect Public Health. 2017;10(6):745-8. doi: 10.1016/j.jiph.2016.11.014. [PubMed: 28215918].
  • 34. Jones N, Ray B, Ranjit KT, Manna AC. Antibacterial activity of ZnO nanoparticle suspensions on a broad spectrum of microorganisms. FEMS Microbiol Lett. 2008;279(1):71-6. doi: 10.1111/j.1574-6968.2007.01012.x. [PubMed: 18081843].
  • 35. Tayel AA, El-Tras WF, Moussa S, El-Baz AF, Mahrous H, Salem MF, et al. Antibacterial action of zinc oxide Nanoparticles against foodborne pathogens. J Food Saf. 2011;31(2):211-8. doi: 10.1111/j.1745-4565.2010.00287.x.
  • 36. Ghaderian HS, Mohammadi Sichani M, Yousefi MH. [Antibacterial activity of ZnO nanoparticles and filters coated with ZnO nanoparticles on eliminating Escherichia coli and Enterococcus faecalis]. Iran J Health Environ. 2014;4(2):37-42. Persian.
  • 37. Atmaca SE, Gul K, Cleck R. The effect of zinc on microbial growth. J Med Sci. 1998;28:595-7.
  • 38. Heinlaan M, Ivask A, Blinova I, Dubourguier HC, Kahru A. Toxicity of nanosized and bulk ZnO, CuO and TiO2 to bacteria Vibrio fischeri and crustaceans Daphnia magna and Thamnocephalus platyurus. Chemosphere. 2008;71(7):1308-16. doi: 10.1016/j.chemosphere.2007.11.047. [PubMed: 18194809].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments